David Allison Ph.D Overview

  • Primary Position
  • Board Member

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 7

  • Med. Deal Size

  • Med. Valuation

David Allison Ph.D General Information

Biography

Dr. David Allison serves as Board Member at IPI Legacy Liquidation. He serves as Managing Director at Westlake Village BioPartners. He serves as Board Member at Soteria Biotherapeutics and Borealis Biosciences. He also serves as Board Member at Recludix Pharma. He has served as a member of our Board of Directors since June 2019. He served as Board Member at Radionetics Oncology and Magnetic Insight. He served as Board Member at 5AM Ventures. He has served as a Partner at 5 AM Venture Management, LLC since July 2018, and was previously a Principal at 5 AM Venture Management, LLC since August 2016. He previously served as a Principal at Versant Ventures from April 2014 to August 2016. Prior to Versant Ventures, He worked at Split Rock Partners as a Principal from August 2009 to August 2014, and at PTV Healthcare Capital as a Senior Associate from 2006 to 2009. He currently serves on the boards of directors of various private companies and as a Director and Audit Committee Member at CinCor Pharma, Inc. (NASDAQ: CINC). He received a Ph.D. in Bioengineering from Rice University and a B.S.E in Biomedical Engineering from The University of Iowa.

Contact Information

Primary Position
Education
Rice University, Ph.D. (Doctor of Philosophy)
University of Iowa, BS (Bachelor of Science)
Gender
Male
Phone
+1 (206)
Address
  • 201 Elliott Avenue West
  • Suite 260
  • Seattle, WA 98119
  • United States
+1 (206)

David Allison Ph.D Positions (1)

Firm name Firm type Title Location Industry Since
Westlake Village BioPartners Investor Managing Director Westlake Village, CA Venture Capital

David Allison Ph.D Board Seats (7)

Company Industry Ownership Status Financing Status Location Since
3T Biosciences Drug Discovery Privately Held (backing) Venture Capital-Backed South San Francisco, CA
Borealis Biosciences Discovery Tools (Healthcare) Privately Held (backing) Venture Capital-Backed Vancouver, Canada
IPI Legacy Liquidation Drug Discovery Privately Held (backing) Formerly VC-backed Seattle, WA
Neurogastrx Therapeutic Devices Privately Held (backing) Venture Capital-Backed Woburn, MA
Recludix Pharma Drug Discovery Privately Held (backing) Venture Capital-Backed San Diego, CA

David Allison Ph.D Lead Partner on Deals (13)

David Allison Ph.D has been the lead partner on 13 deals. Their latest deal was with Borealis Biosciences, a discovery tools (healthcare) company. The deal was made for on 27-Nov-2024.

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Borealis Biosciences 27-Nov-2024 Early Stage VC (Series A) Completed Discovery Tools (Healthcare) Vancouver, Canada
Radionetics Oncology 03-Jan-2024 Completed Drug Discovery Menlo Park, CA
Recludix Pharma 15-Nov-2021 Completed Drug Discovery San Diego, CA
Magnetic Insight 01-Oct-2021 Completed Diagnostic Equipment Alameda, CA
CinCor Pharma 22-Sep-2021 Completed Drug Discovery Waltham, MA
Soteria Biotherapeutics 17-May-2021 Completed Drug Discovery San Mateo, CA
CinCor Pharma 14-May-2019 Completed Drug Discovery Waltham, MA
Magnetic Insight 11-Dec-2018 Completed Diagnostic Equipment Alameda, CA
IPI Legacy Liquidation 06-Dec-2018 Later Stage VC (Series D) Completed Drug Discovery Seattle, WA
Neurogastrx 01-Aug-2018 Later Stage VC (Series A) Completed Therapeutic Devices Woburn, MA

David Allison Ph.D Network (197)

Board Members (106)

Name Company Representing Location From
Mette Agger ScPharmaceuticals Lundbeckfonden BioCapital Burlington, MA
Zachary Hornby Radionetics Oncology Self Menlo Park, CA
Magnetic Insight Celesta Capital Alameda, CA
Magnetic Insight ChinaEquity Group Alameda, CA
ScPharmaceuticals Self Burlington, MA

Portfolio Executives (79)

Name Company Role Deal date Location
Jerel Davis Ph.D Borealis Biosciences Chairman 27-Nov-2024 Vancouver, Canada
Christian Hordo Borealis Biosciences Chief Executive Officer 27-Nov-2024 Vancouver, Canada
Radionetics Oncology Chief Executive Officer & Board Member 03-Jan-2024 Menlo Park, CA
Radionetics Oncology Founding Member & Chief Research Officer 03-Jan-2024 Menlo Park, CA
Radionetics Oncology Chief Operating Officer 03-Jan-2024 Menlo Park, CA

Fund Team Members (12)

Name Investor Fund Fund Location
Beth Seidenberg MD Westlake Village BioPartners Westlake BioPartners Fund II Westlake Village, CA
Beth Seidenberg MD Westlake Village BioPartners Westlake BioPartners Fund I Westlake Village, CA
5AM Ventures San Francisco, CA
Westlake Village BioPartners Westlake Village, CA
5AM Ventures San Francisco, CA

David Allison Ph.D Affiliated Funds (6)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
5AM Opportunities II 5AM Ventures Venture Capital - Later Stage Closed 2021
5AM Ventures VI 5AM Ventures Venture Capital - Early Stage Closed 2018
Westlake BioPartners Fund II Westlake Village BioPartners Venture - General Closed 2022
5AM Opportunities I 5AM Ventures Venture Capital - Later Stage Closed 2018
5AM Ventures V 5AM Ventures Venture Capital - Early Stage Closed 2016

David Allison Ph.D FAQs

  • Who is David Allison Ph.D?

    Dr. David Allison serves as Board Member at IPI Legacy Liquidation.

  • How much does David Allison Ph.D typically invest?

    David Allison Ph.D's median deal size is .

  • What is David Allison Ph.D’s main position?

    David Allison Ph.D’s primary position is Board Member.

  • How many active board seats does David Allison Ph.D hold?

    David Allison Ph.D holds 7 board seats including 3T Biosciences, Borealis Biosciences, IPI Legacy Liquidation, Neurogastrx, and Recludix Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »